Mohammed Lilo

687 citations
19 papers · 500 indexed · h-index 11

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
  • Dermatology top 10%
    • Cancer and Skin Lesions

Papers in

    • CAR-T cell therapy research 2
    • Cancer Immunotherapy and Biomarkers 2
    • Polyomavirus and related diseases 2

Mohammed Lilo

19 papers receiving 491 citations

Peers

Mohammed Lilo
Comparison fields: 5 of 59
  • Oncology 318
  • Dermatology 57
  • Immunology 124
  • Epidemiology 140
  • Ophthalmology 26
Replace Yukiko Teramoto with:
Yukiko Teramoto Japan
Megan D. Schollenberger United States
Lyndon Su United States
Martín Sangüeza United States
Christopher Lum United States
Samuel Bieligk United States
Maria Elena Errico Italy
Sapna M. Amin United States
Hermann Kneitz Germany
Julie Y. Tse United States
Mohammed Lilo relative to Yukiko Teramoto Japan Yukiko Teramoto's profile →
Citations per field
00.5×1.5×2.2×
Yukiko Teramoto · 1×
Citations per year

Countries citing papers authored by Mohammed Lilo

Since Specialization
Citations

This map shows the geographic impact of Mohammed Lilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Lilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Lilo more than expected).

Fields of papers citing papers by Mohammed Lilo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Lilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Lilo. The network helps show where Mohammed Lilo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mohammed Lilo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mohammed Lilo Line = papers co-authored together Mohammed Lilo links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20209
2 20193
3 201863
4 20182
5 201713
6 201723
7 2017115
8 201714
9 201712
10 2017157
11 20172
12 201619
13 201617
14 20165
15 201521
16 20151
17 20151
18 201422
19
Toxic epidermal necrolysis.
20141

About Mohammed Lilo

Mohammed Lilo is a scholar working on Toxicology, Oncology, Dermatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 500 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Head and Neck Anomalies (2 papers), CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Polyomavirus and related diseases (2 papers), Nonmelanoma Skin Cancer Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (318 citations), Dermatology (57 citations), Immunology (124 citations), Epidemiology (140 citations) and Ophthalmology (26 citations). Mohammed Lilo has collaborated with scholars based in United States, Lebanon and Taiwan. Frequent co-authors include Robert E. LeBlanc, Evan J. Lipson, Janis M. Taube, Jessica Esandrio, Aleksandra Ogurtsova, Youdinghuan Chen, Haiying Xu, William H. Sharfman, Megan D. Schollenberger and Derek B. Allison. Their work appears in journals such as Cancer Cytopathology, American Journal of Dermatopathology, Acta Cytologica, Diagnostic Cytopathology and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026